References
- Paoloni JA, Milne C, Orchard J, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) in sports medicine: guidelines for practical but sensible use. Br J Sports Med. 2009;43(11):863–865.
- Thomas T, Mottram D, Waldock C. Advising patients on prevention and management of sporting injuries in the pharmacy. Pharm J. 2016;297:7892.
- Massey T, Derry S, Moore RA, et al. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev. 2010;(6):CD007402.
- Busson M. Update on ibuprofen: review article. J Int Med Res. 1986;14(2):53–62.
- Bradbury F. How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice. Int J Clin Pract Suppl. 2004; 144:27–32.
- Bushra R, Aslam N. An overview of clinical pharmacology of ibuprofen. Oman Med J. 2010;25(3):155–1661.
- Whitefield M, O’Kane CJ, Anderson S. Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study. J Clin Pharm Ther. 2002;27(6):409–417.
- Patel A, Bell M, O’Connor C, et al. Delivery of ibuprofen to the skin. Int J Pharm. 2013;457(1):9–13.
- Beaver WT. Review of the analgesic efficacy of ibuprofen. Int J Clin Pract Suppl. 2003; 135:13–17.
- Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60(3):555–574.
- Machen J, Whitefield M. Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double-blind, placebo-controlled study. Int J Clin Pract. 2002;56(2):102–106.
- Mazieres B. Topical ketoprofen patch. Drugs R D. 2005;6(6):337–344.
- Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17(6):275–342.
- Barkin RL. Topical nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and therapeutic outcome. Am J Ther. 2015;22(5):388–407.
- Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2012;9:CD007400.
- Mason L, Moore RA, Edwards JE, et al. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract. 2004;5:10.
- Bershow A, Warshaw E. Cutaneous reactions to transdermal therapeutic systems. Dermatitis. 2011;22(4):193–203.
- Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs. 1992;44(3):498–529.
- Shelanski HA, Shelanski MV. A new technique of human patch tests. Proc. Sci. Sect. Toilet Goods Assoc. 1953;19:46–49.
- U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER).Guidance for industry: FDA guidance: skin irritation and sensitization testing of generic transdermal drug products. 1999 [cited 2017 Jul 3]. Available from: https://www.fda.gov/ohrms/dockets/98fr/990236Gd.pdf
- Alves C, Romeira AM, Abreu C, et al. Non-steroidal anti-inflammatory drug hypersensitivity in children. Allergol Immunopathol (Madr). 2017;45(1):40–47.
- Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, et al. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: an update. Pharmaceuticals (Basel). 2010;3(1):10–18.
- Campbell J, Dunn T. Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. J Accid Emerg Med. 1994;11(3):178–182.
- Ale I, Lachapelle JM, Maibach HI. Skin tolerability associated with transdermal drug delivery systems: an overview. Adv Ther. 2009;26(10):920–935.
- Musel AL, Warshaw EM. Cutaneous reactions to transdermal therapeutic systems. Dermatitis. 2006;17(3):109–122.